Perspective of patients with autoimmune diseases on COVID-19 vaccination.
作者信息
Boekel Laura, Hooijberg Femke, van Kempen Zoé L E, Vogelzang Erik H, Tas Sander W, Killestein Joep, Nurmohamed Michael T, Boers Maarten, Kuijpers Taco W, van Ham S Marieke, Eftimov Filip, Wieske Luuk, Rispens Theo, Wolbink Gertjan J
机构信息
Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam 1056 AB, Netherlands.
Department of Neurology, Vrije Universiteit, Amsterdam UMC, Amsterdam, Netherlands.
出版信息
Lancet Rheumatol. 2021 Apr;3(4):e241-e243. doi: 10.1016/S2665-9913(21)00037-0. Epub 2021 Feb 22.
Abstract
摘要
相似文献
1
Perspective of patients with autoimmune diseases on COVID-19 vaccination.
Lancet Rheumatol. 2021 Apr;3(4):e241-e243. doi: 10.1016/S2665-9913(21)00037-0. Epub 2021 Feb 22.
2
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.
Lancet Rheumatol. 2021 Nov;3(11):e778-e788. doi: 10.1016/S2665-9913(21)00222-8. Epub 2021 Aug 6.
3
New-onset autoimmune phenomena post-COVID-19 vaccination.
Immunology. 2022 Apr;165(4):386-401. doi: 10.1111/imm.13443. Epub 2022 Jan 7.
4
Autoimmune hepatitis with history of HCV treatment triggered by COVID-19 vaccination: case report and literature review.
Clin J Gastroenterol. 2022 Aug;15(4):791-795. doi: 10.1007/s12328-022-01654-0. Epub 2022 Jun 18.
5
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
RMD Open. 2021 Feb;7(1). doi: 10.1136/rmdopen-2021-001594.
6
Psychological and quality of life effects of vaccination against COVID-19 in patients with systemic autoimmune diseases.
Lupus. 2022 Dec;31(14):1808-1815. doi: 10.1177/09612033221134203. Epub 2022 Nov 10.
7
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases.
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI68-SI76. doi: 10.1093/rheumatology/keab432.
8
Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases.
J Rheumatol. 2021 Aug;48(8):1330-1339. doi: 10.3899/jrheum.210288. Epub 2021 May 15.
9
COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
J Korean Med Sci. 2021 Mar 29;36(12):e95. doi: 10.3346/jkms.2021.36.e95.
10
The Relationship Between Health Literacy and Quality of Life, Attitudes and Perceptions of Covid-19 and Vaccination Among Patients with Systemic Autoimmune Diseases.
Clin Nurs Res. 2022 Jul;31(6):981-990. doi: 10.1177/10547738221090558. Epub 2022 Apr 28.
引用本文的文献
1
Acceptance and awareness of COVID-19 vaccine among healthcare professionals and students in India. A questionnaire based study.
J Family Med Prim Care. 2025 May;14(5):2031-2036. doi: 10.4103/jfmpc.jfmpc_1753_24. Epub 2025 May 31.
2
Safety of COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases: A Cross-sectional Study in Egypt.
Oman Med J. 2024 Sep 30;39(5):e676. doi: 10.5001/omj.2024.107. eCollection 2024 Sep.
3
Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease- a survey of the NeuroCOVID-19 task force of the European Academy of Neurology.
Neurol Sci. 2025 Apr;46(4):1467-1476. doi: 10.1007/s10072-025-08017-w. Epub 2025 Feb 4.
4
Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review.
Rheumatol Int. 2024 Dec;44(12):2757-2794. doi: 10.1007/s00296-024-05734-x. Epub 2024 Nov 22.
5
Interventions to Improve COVID-19 Vaccine Hesitancy.
Rheum Dis Clin North Am. 2025 Feb;51(1):61-73. doi: 10.1016/j.rdc.2024.09.007. Epub 2024 Oct 11.
6
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases.
Eur J Neurol. 2024 Dec;31(12):e16409. doi: 10.1111/ene.16409. Epub 2024 Sep 5.
7
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus.
JCI Insight. 2024 Mar 8;9(5):e176556. doi: 10.1172/jci.insight.176556.
8
Understanding COVID-19 vaccine hesitancy in vasculitis patients.
Front Public Health. 2023 Dec 4;11:1301492. doi: 10.3389/fpubh.2023.1301492. eCollection 2023.
9
SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey.
Rheumatol Int. 2024 Jan;44(1):81-87. doi: 10.1007/s00296-023-05489-x. Epub 2023 Oct 31.
10
Adoption rates of recommended vaccines and influencing factors among patients with inflammatory arthritis: a patient survey.
Rheumatol Int. 2024 Jan;44(1):165-172. doi: 10.1007/s00296-023-05476-2. Epub 2023 Oct 14.
本文引用的文献
1
Willingness to get the COVID-19 vaccine with and without emergency use authorization.
Am J Infect Control. 2021 Feb;49(2):137-142. doi: 10.1016/j.ajic.2020.11.018. Epub 2020 Nov 20.
2
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
Lancet. 2020 Nov 21;396(10263):1614-1616. doi: 10.1016/S0140-6736(20)32318-7. Epub 2020 Nov 4.
3
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.
Ann Rheum Dis. 2021 Mar;80(3):384-391. doi: 10.1136/annrheumdis-2020-218946. Epub 2020 Oct 13.
4
Determinants of Vaccination Uptake in Risk Populations: A Comprehensive Literature Review.
Vaccines (Basel). 2020 Aug 27;8(3):480. doi: 10.3390/vaccines8030480.
5
Vaccination of patients with autoimmune inflammatory rheumatic diseases.
Nat Rev Rheumatol. 2015 Mar;11(3):135-45. doi: 10.1038/nrrheum.2014.206. Epub 2014 Dec 9.
Zotero 插件